![Christine Guillen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Christine Guillen is the founder and currently serves as the Chief Executive Officer & Director of ElsaLys Biotech SAS, a company she founded in 2013.
Prior to founding ElsaLys Biotech SAS, she held the position of Director-Project Management at EUSA Pharma SAS from 2005 to 2007 and Head-External Programs at Transgene SA from 2007 to 2013.
Anciens postes connus de Christine Guillen
| Sociétés | Poste | Fin |
|---|---|---|
| ELSALYS BIOTECH | Fondateur | - |
| TRANSGENE | Corporate Officer/Principal | 01/01/2013 |
EUSA Pharma SAS
 EUSA Pharma SAS BiotechnologyHealth Technology Specializes in pharmaceutical research for rare diseases | Corporate Officer/Principal | 01/10/2007 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
26
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Transgene SA
 Transgene SA BiotechnologyHealth Technology Designs and develops therapeutic vaccines and oncolytic viruses for the treatment of cancer | Health Technology |
EUSA Pharma SAS
EUSA Pharma SAS BiotechnologyHealth Technology Specializes in pharmaceutical research for rare diseases | Health Technology |
ElsaLys Biotech SAS
 ElsaLys Biotech SAS Pharmaceuticals: MajorHealth Technology Designs, develops and supplies antibodies to modulate the immune system of patients | Health Technology |
